There will Opinion Piece Weigh in on Medicare Prescription Drug Benefit.

There will Opinion Piece Weigh in on Medicare Prescription Drug Benefit, USA Two newspapers recently an editorial and an opinion piece addressing the new Medicare prescription drug benefit published. Summaries appear below.

New York Times: The new Medicare Prescription Drug benefit is a ‘promising start ‘as ‘the first step towards dealing with an important modern necessity, ‘a Times editorial states. However, if ‘the drug coverage program is to believe the hopes of Republicans that it private insurance companies private insurance, to be fair, it will need to be legions of healthy people who do not with many drugs, the costs to of offset heavy users, ‘said the editor (New York Times.These findings are importance, restarted, novel features new functions on several shared foot and NPHP proteins at the cilliary transitional area, a structure to ciliary for any subtypes from unicellular protists to humans. Which information helps about patients patients having with mutations in two ciliary disease gene products with serious symptoms. Sources: UCD Conway Institute of Biomolecular & Biomedical Research, AlphaGalileo Foundation.

The Company application for authorization on the German health authorities submitted for license a to the market SEROQUEL at in France for treating schizophrenia and acute manic episodes in bipolar disease. Permission by Health Canada market SEROQUEL was obtained as a monotherapy for the both acute management from of manic episodes in bipolar disorder.